The biosynthesis of the secretory core gene product of the woodchuck hepatitis virus (WHV) was studied in human cells. We have shown that the WHV e antigen was a N-glycosylated (most likely a diglycosylated) protein, with an apparent M r of 24K. To demonstrate that the WHV precore protein was correctly processed in human cells, we engineered chimeric proteins in which signal peptides or arginine-rich domains of WHV and hepatitis B virus (HBV) precore proteins were exchanged. Our results showed that both the signal peptide and the arginine-rich region of WHV precore protein were cleaved off during the secretion pathway, as previously reported for precore protein of human HBV and duck HBV. These observations demonstrate that the maturation process of the e antigen is conserved in hepadnaviruses. In addition, on the basis of inhibition experiments, we suggest that the cleavage of the carboxy terminus of the WHV precore protein occurred in a post-endoplasmic reticulum compartment, most likely beyond the medial Golgi, and that this cleavage was catalysed by an aspartyl protease.
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The hepadnavirus C open reading frame (ORF) contains two in-phase ATG codons, delimiting the precore sequence (pre-C sequence) and the C gene. It has been shown that, for the human hepatitis B virus (HBV) and the duck hepatitis B virus (DHBV), initiation of translation at the pre-C AUG leads to the synthesis of the precore protein which was demonstrated to be the precursor of the secreted e antigen (Ou et al., 1986; Roossinck et al., 1986; McLachlan et al., 1987; Schlicht et al., 1987; Standring et al., 1988) . A signal peptide sequence encoded by the pre-C region directs the precore protein to the endoplasmic reticulum (ER). The cotranslational cleavage of this signal peptide by signal peptidase leads to the immature e antigen. A second processing event, most likely occurring at one of the final steps of the secretory pathway, removes the arginine-rich carboxy terminus of this precursor (Garcia et al., 1988; Jean-Jean et al., 1989a; Nassal et al., 1989; Wang et al., 1991; Schlicht, 1991) . At the end of this process, the e antigen is excreted.
Although it is established that the e antigen is dispensable for viral viability (Chang et al., 1987; Tong et al., 1991 ; Chen et al., 1992) , conservation of the pre-C sequence during evolution suggests that the e antigen has an important role in the life cycle of hepadnaviruses. It was postulated that the function of HBV e antigen (HBeAg) could be to induce T cell tolerance in utero (Milich et al., 1990) .
Recently, it was reported that the pre-C sequence of the woodchuck hepatitis virus (WHV) may be important for chronic infection in the natural host (Chen et al., 1992) . So far, documented proof for the existence of a WHV e antigen has never been reported although the presence of an e antigen/anti-e antigen system in the blood of WHV-infected Eastern woodchucks was demonstrated by indirect immunological methods (Hantz et al., 1983) . We have hence studied the expression and the processing of the product of the entire WHV C ORF. For these experiments, human 293 cells (Harrison et al., 1977) were employed, because they have been shown to be competent for HBeAg secretion (Jean-Jean et al., 1989a) .
Analysis of the amino acid sequence deduced from the nucleotide sequence of the WHV C gene (Galibert et al., 1982) shows that the putative WHV precore protein contains two potential N-glycosylation sites: Asnl04-Ile-Thr and Asn~lg-Asp Thr as is the case with many secretory proteins, including the DHBV e antigen (DHBeAg). To verify that WHV precore protein is actually N-glycosylated, 293 cells were transfected with plasmid pWPC by the calcium phosphate method (Graham & Van der Eb, 1973 All of the concentrated m e d i u m was subjected to i m m u n o p r e c i p i t a t i o n using 5 ~tl of rabbit anti-woodchuck hepatitis core antigen antiserum (Weimer et al., 1987) . After i m m u n o p r e c i p i t a t i o n , proteins were separated on 0-15% S D S -1 2 -5 % p o l y a c r y l a m i d e gels (Laemmli, 1970) . Transient expression o f p W P C led to the a p p e a r a n c e in the culture m e d i u m o f a 24K protein ( Fig To demonstrate that W H e A g is an N-glycosylated protein, two experiments were done. In the first one, the a n t i -W H e A g i m m u n o p r e c i p i t a t e d protein was treated with endoglycosidase F (Boehringer M a n n h e i m ) as described by Schlicht et al. (1987) . As shown in Fig. 1 (a, right lane), after digestion with 0.5 units of endoglycosidase F, the protein had an a p p a r e n t M,. o f 18K which corresponds to the Mr calculated from the amino acid sequence. In the second experiment, cells were grown in the presence o f tunicamycin (Sigma), an inhibitor of the first step of the N-glycosylation process. As shown in abolished in 6 gM-tunicamycin-treated cells. To show that it was not due to a general inhibition of protein export, the effect o f tunicamycin on the secretion of HBeAg, an unglycosylated protein, was studied. Cells were transfected with plasmid p H P C , expressing the HBV precore protein under the control of the M L P , and the culture m e d i u m was i m m u n o p r e c i p i t a t e d by a rabbit anti-hepatitis B core antigen antiserum (Dako) . Fig 2( b) shows that tunicamycin had only a slight effect on HBeAg secretion, confirming that the 24K protein was N-glycosylated. Although the WHV precore protein contains two potential sites for N-glycosylation, it is worth noting that in our experiments only one form of WHeAg was observed. According to the shift observed in its electrophoretic mobility (Sawhney et al., 1991) , the 24K protein was most likely the diglycosylated form of the 18K protein, suggesting that the N-glycosylation of this antigen was very efficient. This is an unexpected result because DHBeAg was found in three different forms (di-, mono-and unglycosylated) in the serum of infected ducks (Schlicht et al., 1987) .
Since both the signal peptide and the arginine-rich domain of WHV precore protein are very similar (respectively 76 and 79 %) to their counterpart in the HBV precore protein, it is tempting to speculate that WHeAg matures through the same processing steps as HBeAg. To verify this hypothesis, we constructed HBV-WHV recombinant plasmids in which either the signal peptide sequences or the carboxy-terminal arginine-rich domain sequences were exchanged (Fig.  2a) . Open reading frames were conserved in these constructions, allowing the synthesis of recombinant HBV-WHV C gene products. Plasmid pHPCS encoded a protein which contains the signal peptide of WHV precore protein, the core and the arginine-rich domain of HBeAg precursor, whereas pHPCR encoded a protein which contains the signal peptide and the core of HBV precore protein followed by the arginine-rich domain of WHV precore protein. Plasmids pWPCS and pWPCR were the respective counterparts of pHPCS and pHPCR. As expected, secretions of chimeric HBeAg and WHV mature precore protein were not impeded by the exchange of either the signal peptide (Fig. 2b0 compare lane 2 to lane 3 and lane 6 to lane 7) or the carboxyterminal sequences (Fig. 2 b , compare lane 2 to lane 4 and lane 6 to lane 8), the variable amount of protein observed being most likely due to differences in transfection efficiencies. It is worth noting that no heterogeneity of the secreted HBeAg or WHeAg was observed. Furthermore, chimeric e antigens carrying heterologous C termini were identical in size with the respective wildtype antigen, strongly suggesting that the cleavage of the C terminus of WHeAg occurs in a sequence highly homologous to the known HBeAg cleavage site (TTVV-RRR) (Takahashi et al., 1983) . Thus, it is probable that the WHeAg cleavage site is HTVI-RRR but further studies are required to confirm this point.
Recent data indicate that the C terminus of the HBeAg precore protein as well as that of the DHBV precore protein is cleaved in a post-ER compartment (Schlicht, 1991 ; Wang et al., 1991) . In an attempt to determine the subcellular compartment in which the C terminus of the WHeAg precursor is cleaved, the cells were grown in the presence of monensin, an ionophore which was reported to block the intracellular transport from the medial to the trans Golgi (Tartakoff, 1983) . As expected, secretion of WHeAg was totally abolished when cells were grown in the presence of this inhibitor (Fig. 3 a) . The same result was obtained for HBeAg in a control experiment. Furthermore, in cell extract, a 29K protein (p29) appeared in pWPC-transfected cells, most likely corresponding to WHeAg precursor (Fig. 3b) whereas the amount of HBeAg precursor (p22) was slightly increased. In addition no mature antigens can be observed in the extracts of cells grown in the presence of monensin. Thus, it could be tentatively suggested that the cleavage of the arginine-rich domain of WHV precore protein occurs beyond the medial Golgi. The same conclusion can be drawn for HBeAg. To verify that the cleavage of Twenty-four hours after transfection with plasmids pHPC or pWPC, 293 cells were grown in the presence of 0-1 mM-pepstatin dissolved in DMSO or in the presence of DMSO alone at the same concentration. Twenty-four hours later, proteins were labelled as described in Fig. 3 and culture media concentrated, aSS-labelled proteins were immunoprecipitated by the appropriate antibodies, then analysed by 12-5 % SDS-PAGE. Lane M, ~4C-labelled standard M~ markers.
Short c o m m u n i c a t i o n
the arginine-rich domain of the WHV precore protein was due to a cellular aspartyl protease as established for the HBeAg precursor (Jean-Jean et al., 1989b) , pWPCtransfected cells were grown in the presence of pepstatin (Boehringer Mannheim), a specific inhibitor of aspartyl proteases (Marciniszyn et al., 1976) . As a control, the same experiment was performed with pHPC-transfected cells that expressed HBeAg. As shown in Fig. 4 , pepstatin at a concentration of 0.1 mN drastically reduced the secretion of both WHeAg and HBeAg indicating that the C-terminal region of WHeAg precursor was cleaved by an aspartyl protease. It could be concluded that the WHV precore protein was correctly matured in human cells. This conclusion is supported by two sets of results. Firstly, the apparent M r of WHeAg was not modified by the presence in the precore protein of foreign signal peptide or C-terminal region, indicating that these two regions were removed during the secretion pathway. Secondly, the M r of WHeAg after endoglycosidase F treatment was 18K, in perfect agreement with the expected M r of WHeAg if we assume that this antigen follows the same processing steps as HBeAg and DHBeAg. Since DHBV precore protein (Schlicht et al., 1987) is processed in human cells, it can be concluded that the maturation process of hepadnavirus e antigens appears to be species-independent.
In this paper we describe for the first time the structure and the biosynthesis of the WHV e antigen. The woodchuck model of viral hepatitis is known to be an excellent model for the study of human hepatocellular carcinoma (Hsu et al., 1988) . It could also be useful to determine the role of the e antigen in the biology of virus infection, as parallel studies could be performed in cell culture and in animals. 
